Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia

NCT07721480 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Beta Thalassemia Transfusion Dependent

Interventions

DRUG: HGI-001 Injection

Sponsor

Prince of Wales Hospital, Shatin, Hong Kong